CRYSTAL GILBERT: Open Payments
NPI 1134406531 · LAWRENCEBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 44 payments from 12 companies in 2025. Trend: 2023 $1,320 · 2024 $1,337 · 2025 $838
Food & beverage: $838
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $188 |
| PFIZER INC. | 12 | $156 |
| GlaxoSmithKline, LLC. | 7 | $120 |
| Lilly USA, LLC | 5 | $78 |
| ABBVIE INC. | 4 | $73 |
| Vanda Pharmaceuticals Inc. | 2 | $54 |
| Novo Nordisk Inc | 3 | $53 |
| SANOFI-AVENTIS U.S. LLC | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Dynavax Technologies Corporation | 1 | $18 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, PREVNAR 20, FANAPT, ELIQUIS, MOUNJARO, TZIELD, Wegovy.
Industry payments across KY — which companies pay providers there.
